These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 31396386)
1. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis. Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386 [TBL] [Abstract][Full Text] [Related]
2. Risk and prognostic factors of breast cancer with liver metastases. Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449 [TBL] [Abstract][Full Text] [Related]
3. Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study. Xiao W; Zheng S; Liu P; Zou Y; Xie X; Yu P; Tang H; Xie X Cancer Med; 2018 Mar; 7(3):922-930. PubMed ID: 29473333 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis. Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884 [TBL] [Abstract][Full Text] [Related]
5. A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study. Xiong Y; Shi X; Hu Q; Wu X; Long E; Bian Y Front Oncol; 2021; 11():600768. PubMed ID: 34150607 [TBL] [Abstract][Full Text] [Related]
6. An effective tool for predicting survival in breast cancer patients with Wang W; Liu J; Chen Y; Xu X; Huo L; Wang X; Gu J Front Surg; 2022; 9():939132. PubMed ID: 36684376 [TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer]. Wu SY; Tan Y; Guan YS Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945 [TBL] [Abstract][Full Text] [Related]
8. Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population. Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B Front Oncol; 2021; 11():670723. PubMed ID: 34046360 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for hormone receptor-positive breast cancer with liver metastasis and establishment of novel nomograms for prediction: a SEER-based study. Xu Z; Chen Y; Dai Y; Chen Y; Ding J Transl Cancer Res; 2023 Dec; 12(12):3672-3692. PubMed ID: 38193003 [TBL] [Abstract][Full Text] [Related]
10. Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study. Zhao HY; Gong Y; Ye FG; Ling H; Hu X Cancer Manag Res; 2018; 10():5937-5950. PubMed ID: 30538544 [TBL] [Abstract][Full Text] [Related]
11. Web-Based Dynamic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Breast Cancer Patients with Lung Metastases. Wang K; Li Y; Wang D; Zhou Z J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675704 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis. Leone BA; Vallejo CT; Romero AO; Machiavelli MR; Pérez JE; Leone J; Leone JP Breast Cancer Res Treat; 2017 Feb; 161(3):537-548. PubMed ID: 27975154 [TBL] [Abstract][Full Text] [Related]
13. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study. Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population. Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Xu B BMC Cancer; 2021 Dec; 21(1):1330. PubMed ID: 34906122 [TBL] [Abstract][Full Text] [Related]
15. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer. Wang Z; Wang H; Ding X; Chen X; Shen K Ther Adv Med Oncol; 2020; 12():1758835920932674. PubMed ID: 32550867 [TBL] [Abstract][Full Text] [Related]
16. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database. Kim YJ; Kim JS; Kim IA J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531 [TBL] [Abstract][Full Text] [Related]
17. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival. Fan Y; Wang Y; He L; Imani S; Wen Q ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135 [TBL] [Abstract][Full Text] [Related]
18. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881 [TBL] [Abstract][Full Text] [Related]
19. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis. He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462 [TBL] [Abstract][Full Text] [Related]
20. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis. Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]